RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
INVO Bioscience - Stock

INVO Bioscience Equity 2024

INVO Bioscience Equity

892,830.01 USD

Ticker

INVO

ISIN

US44984F4019

In 2024, INVO Bioscience's equity was 892,830.01 USD, a -191.11% increase from the -980,000.02 USD equity in the previous year.

INVO Bioscience Aktienanalyse

What does INVO Bioscience do?

INVO Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing INVO Bioscience's Equity

INVO Bioscience's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding INVO Bioscience's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating INVO Bioscience's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

INVO Bioscience's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in INVO Bioscience’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about INVO Bioscience Stock

What is the equity of INVO Bioscience this year?

INVO Bioscience has equity of 892,830.01 USD this year.

What was the equity of INVO Bioscience compared to the previous year?

The equity of INVO Bioscience has increased/decreased by -191.11% decreased compared to the previous year.

What impact does a high equity have on investors of INVO Bioscience?

A high equity is advantageous for investors of INVO Bioscience as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of INVO Bioscience?

A low equity can be a risk for investors of INVO Bioscience, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of INVO Bioscience affect the company?

An increase in equity of INVO Bioscience can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of INVO Bioscience affect the company?

A reduction in equity of INVO Bioscience can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of INVO Bioscience?

Some factors that can affect the equity of INVO Bioscience include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of INVO Bioscience so important for investors?

The equity of INVO Bioscience is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can INVO Bioscience take to change the equity?

To change equity, INVO Bioscience can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does INVO Bioscience pay?

Over the past 12 months, INVO Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, INVO Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of INVO Bioscience?

The current dividend yield of INVO Bioscience is .

When does INVO Bioscience pay dividends?

INVO Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of INVO Bioscience?

INVO Bioscience paid dividends every year for the past 0 years.

What is the dividend of INVO Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is INVO Bioscience located?

INVO Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von INVO Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of INVO Bioscience from 6/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/28/2024.

When did INVO Bioscience pay the last dividend?

The last dividend was paid out on 6/28/2024.

What was the dividend of INVO Bioscience in the year 2023?

In the year 2023, INVO Bioscience distributed 0 USD as dividends.

In which currency does INVO Bioscience pay out the dividend?

The dividends of INVO Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von INVO Bioscience

Our stock analysis for INVO Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of INVO Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.